Invention Grant
US09381237B2 Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications
有权
鼻病毒的中和免疫原（NimIV）及其在疫苗应用中的应用
- Patent Title: Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications
- Patent Title (中): 鼻病毒的中和免疫原（NimIV）及其在疫苗应用中的应用
-
Application No.: US14182731Application Date: 2014-02-18
-
Publication No.: US09381237B2Publication Date: 2016-07-05
- Inventor: Kirill Kalnin , Yanhua Yan , Harold Kleanthous
- Applicant: Sanofi Pasteur Biologics, LLC
- Applicant Address: US MA Cambridge
- Assignee: Sanofi Pasteur Biologics, LLC
- Current Assignee: Sanofi Pasteur Biologics, LLC
- Current Assignee Address: US MA Cambridge
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Main IPC: A61K39/125
- IPC: A61K39/125 ; C07K14/005 ; C07K16/10 ; A61K39/12 ; A61K39/00
Abstract:
The invention relates to methods and compositions for preventing or treating human rhinovirus infection.
Public/Granted literature
- US20140161833A1 NOVEL NEUTRALIZING IMMUNOGEN (NIMIV) OF RHINOVIRUS AND ITS USES FOR VACCINE APPLICATIONS Public/Granted day:2014-06-12
Information query
